Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 281, Issue 6 50-6, 2001, Pages

  Ming, Y U ^a   Gopalakrishnan, Venkat ^a   Wilson, Thomas W ^a   Robert McNeill, J ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Angiotensin II; Blood pressure; Bosentan; Cardiac output; Deoxycorticosterone acetate; Total peripheral resistance

Indexed keywords

ANGIOTENSIN; ARGIPRESSIN; BOSENTAN; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; VASOPRESSIN;

ARTICLE; BLOOD VESSEL REACTIVITY; HEART OUTPUT; HEMODYNAMICS; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE;

EID: 0035658508     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.281.6.h2511     Document Type: Article

References (28)

1. Endothelin contributes to the hemodynamic effects of vasopressin in spontaneous hypertension
2. Radiotelemetric versus externalized catheter monitoring of blood pressure: Effect of vasopressin in spontaneous hypertension
3. Effect of an endothelin antagonist on hemodynamic responses to angiotensin II
4. Telemetric monitoring of cardiovascular parameters in conscious spontaneously hypertensive rats
5. In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats
6. Increase in number of Weibel-Palade bodies and endothelin-1 release from endothelial cells in the cadmiumtreated rat thoracic aorta
7. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin
8. Why are circulating concentrations of endothelin-1 so low?
9. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells
10. Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats
11. Blood pressure and small arteries in DOCA-salt-treated genetically AVP-deficient rats: Role of endothelin
12. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats
13. Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats
14. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetatesalt hypertensive but not in spontaneously hypertensive rats
15. Pressor response to vasopressin and impaired baroreflex function in DOCA-salt hypertension
16. Pathophysiology of endothelin in the cardiovascular system
17. Hemodynamic effects of vasopressin compared with angiotensin II in conscious rats
18. Weibel-Palade bodies as a storage site of calcitonin gene-related peptide and endothelin-1 in blood vessels of the rat carotid body
19. Secretory pathways in endothelin synthesis
20. Development of DOCA-salt hypertension in the brattleboro rat
21. Endothelin: Potential role in hypertension and vascular hypertrophy
22. Vascular angiotensin II receptors in renal and DOCA-salt hypertensive rats
23. Arginine-vasopressin increases the release of ET-1 into perfusate of rat mesenteric artery
24. Polar secretion of endothelin-1 by cultured endothelial cells
25. New cytoplasmic components in arterial endothelia
26. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
27. Total peripheral conductance mediates antihypertensive effect of nonpeptide mixed endothelin receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats
28. Role of endothelin and vasopressin in DOCA-salt hypertension